%PDF-1.3
%
1 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\W'gQYđkC/2P&$Ʉ9тZ+YZ,hZ:H KEP6a/;=)r
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\W'gQYđkC/2P&$Ʉ9тZ+YZ,hZ:H KEP6a/;=)r
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\W'gQYđkC/2P&$Ʉ9тZ+YZ,hZ:H KEP6a/;=)r
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\W'gQYđkC/2P&$Ʉ9тZ+YZ,hZ:H KEP6a/;=)r
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\W'gQYđkC/2P&$Ʉ9тZ+YZ,hZ:H KEP6a/;=)r
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\W'gQYđkC/2P&$Ʉ9тZ+YZ,hZ:H KEP6a/;=)r
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 133>>stream
xͱ ᝧ8c;X,bB\W'gQYđkC/2P&$Ʉ9тZ+YZ,hZ:H KEP6a/;=)r
endstream
endobj
10 0 obj
<>stream
2022-04-19T22:27:07+05:30
Arbortext Advanced Print Publisher 9.0.114/W
2022-04-26T16:31:09-07:00
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
application/pdf
MAB-2021-0063-ver9-Tanaka_3P 80..86
uuid:2caf7942-1da7-4165-b0b8-4fd0d6446183
uuid:69558b43-6e5d-4507-9e07-20396ba93c5c
endstream
endobj
11 0 obj
<>stream
x+ |
endstream
endobj
12 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
13 0 obj
<>stream
x+ |
endstream
endobj
14 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
15 0 obj
<>stream
x+ |
endstream
endobj
16 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
17 0 obj
<>stream
x+ |
endstream
endobj
18 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
19 0 obj
<>stream
x+ |
endstream
endobj
20 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
21 0 obj
<>stream
x+ |
endstream
endobj
22 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
23 0 obj
<>stream
x+ |
endstream
endobj
24 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
26 0 obj
<>stream
/GS1 gs
BT
/F4 1 Tf
9.843 0 0 9.843 59.7543 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(we)-413.2(have)-415.7(not)-412.4(established)-413(anti-GPCR)-417.3(mAbs,)-412.9(using)-414.4(the)-407.8(syn-)]TJ
0 -1.1174 TD
[(thetic)-401(peptide)-396.2(immunization)-398.7(method)-395(yet.)-393.9(In)-393.8(this)-396.1(study,)-394.8(we)]TJ
0 -1.1116 TD
[(developed)-583.7(anti-mouse)-584.8(CCR2)-583.5(\(mCCR2\))-582.2(mAbs)-582.3(using)-575.6(the)]TJ
T*
[(synthetic)-283.1(peptide)-286.8(immunization)-283.5(method.)]TJ
/F6 1 Tf
8.9663 0 0 8.9663 59.7543 670.3369 Tm
[(Materials)-339(and)-331.9(Methods)]TJ
/F9 1 Tf
0 -1.8336 TD
[(Cell)-336.3(lines)]TJ
/F4 1 Tf
9.843 0 0 9.843 69.7323 637.455 Tm
[(Chinese)-575.5(hamster)-575.6(ovary)-576.8(\(CHO\)-K1)-576.8(and)-568.9(P3X63Ag8U.1)]TJ
-1.0137 -1.1116 TD
[(\(P3U1\))-243.4(cells)-238.3(were)-238(obtained)-241.8(from)-235.9(the)-240.7(American)-239.1(Type)-237.2(Culture)]TJ
0 -1.1174 TD
[(Collection)-366.2(\()-81.7(Manassas,)-367.4(VA\).)-359.8(The)-357(L1210)-363.8(\(murine)-361.5(leukemia\))]TJ
0 -1.1116 TD
[(cell)-439(line)-432(was)-431.4(obtained)-437.6(from)-431.8(the)-430.8(Cell)-433.1(Resource)-439.3(Center)-430.5(for)]TJ
T*
[(Biomedical)-380(Research)-382.9(Institute)-374.2(of)-376.5(Development,)-378.5(Aging)-375.1(and)]TJ
0 -1.1174 TD
[(Cancer,)-521.4(Tohoku)-520.4(University)-520.1(\()-81.7(Miyagi,)-519.2(Japan\).)-519(Synthesized)]TJ
0 -1.1116 TD
[(DNA)-587.6(\(Eurons)-591.3(Genomics)-583.4(KK,)-589.1(Tokyo,)-586.1(Japan\))-584.7(encoding)]TJ
T*
[(mCCR2)-292.1(\(Accession)-297.3(No.)-288.7(NM_009915\))-295(was)-293.1(subcloned)-288.6(into)-292.6(a)]TJ
0 -1.1174 TD
[(pCAG-Ble)-474.7(vector)-475.6(\(FUJIFILM)-473(Wako)-474.4(Pure)-471.9(Chemical)-475.6(Cor-)]TJ
0 -1.1116 TD
[(poration,)-197.9(Osaka,)-196.3(Japan\),)-196.5(after)-198(which)-197.7(the)-194.7(mCCR2)-194.2(plasmid)-194.5(was)]TJ
T*
[(transfected)-229.9(using)-230.1(a)-221.1(Neon)-225.3(transfection)-229.9(system)-227.6(\(Thermo)-230.1(Fisher)]TJ
T*
[(Scientic,)-212.7(Inc.,)-207.1(Waltham,)-207.3(MA\).)-210.1(Subsequently,)-209(CHO/mCCR2)]TJ
0 -1.1174 TD
[(was)-500.5(established)-505.2(using)-500.8(a)-497.6(cell)-502.3(sorter)-503(\(SH800;)-498.1(Sony)-499.6(Corp.,)]TJ
0 -1.1116 TD
[(Tokyo,)-234.8(Japan\),)-231(following)-230(cultivation)-234(in)-227(a)-226.9(medium)-235(containing)]TJ
T*
[(0.5)-166.9(mg/mL)-285.8(Zeocin)-281(\(InvivoGen,)-281.5(San)-280.8(Diego,)-287.6(CA\).)]TJ
1.0137 -1.1174 TD
[(CHO-K1,)-278.6(P3U1,)-267.7(CHO/mCCR2,)-279.8(and)-275.2(L1210)-271.7(were)-272.5(cultured)]TJ
-1.0137 -1.1116 TD
[(in)-290.3(a)-290.2(Roswell)-287.3(Park)-287.6(Memo)-7.7(rial)-288(Institute)-287.8(\(RPMI\))-290.5(1640)-286.6(medium)]TJ
T*
[(\(Nacalai)-285.3(Tesque,)-284.1(Inc.,)-282(Kyoto,)-280.7(Japan\))-279.4(that)-282.3(was)-281.6(supplemented)]TJ
0 -1.1174 TD
[(with)-184.1(10%)-182.9(heat-inactivated)-186.5(fetal)-186.6(bovine)-180.7(serum)-186.2(\(Thermo)-184(Fisher)]TJ
0 -1.1116 TD
[(Scientic,)-385.5(Inc.\),)-381(100)-383.4(units/mL)-380.1(penicillin,)-386(100)]TJ
/F10 1 Tf
18.9034 0 TD
(l)Tj
/F4 1 Tf
.5529 0 TD
[(g/mL)-381.3(strep-)]TJ
-19.4563 -1.1116 TD
[(tomycin,)-359.4(and)-355.8(0.25)]TJ
/F10 1 Tf
7.6201 0 TD
(l)Tj
/F4 1 Tf
.5529 0 TD
[(g/mL)-358.3(amphotericin)-358.1(B)-353.5(\(Nacalai)-365.9(Tesque,)]TJ
-8.173 -1.1174 TD
[(Inc.\).)-490.4(Then,)-494(cells)-485.9(were)-491.4(grown)-490.2(in)-491.9(a)-486.1(humidied)-490.5(incubator,)]TJ
0 -1.1116 TD
[(which)-284.1(was)-281.6(supplied)-280.7(with)-282(5%)-285.5(CO)]TJ
7.3823 0 0 6.5614 190.6582 394.696 Tm
(2)Tj
9.843 0 0 9.843 197.1212 396.3401 Tm
[(and)-280.9(95%)-280.8(air)-281(at)-280(37)]TJ
/F8 1 Tf
7.1939 0 TD
()Tj
/F4 1 Tf
.3974 0 TD
(C.)Tj
/F9 1 Tf
8.9663 0 0 8.9663 59.7543 374.3999 Tm
(Antibodies)Tj
/F4 1 Tf
9.843 0 0 9.843 69.7323 357.959 Tm
[(The)-299.4(anti-mCCR)-9.9(2)-294.8(mAb)-304.9(\(clone)-302.8(EPR20844\))-299.9(was)-298.9(purchased)]TJ
-1.0137 -1.1116 TD
[(from)-282(Abcam)-286.4(\(Cambridge,)-284.1(United)-285.4(Kingdom\).)-279.4(The)-282.1(secondary)]TJ
T*
[(Alexa)-435.1(Fluor)-431.7(488-conjugated)-439.6(anti-rat)-431.9(IgG)-436.1(and)-430.7(Alexa)-435(Fluor)]TJ
0 -1.1174 TD
[(488-conjugated)-451.1(anti-rabbit)-452.6(IgG)-447.6(were)-445.3(purchased)-450.9(from)-449.1(Cell)]TJ
0 -1.1116 TD
[(Signaling)-282(Technology)-8.9(,)-279.9(Inc.)-278.6(\(Danvers,)-285.9(MA\).)]TJ
/F9 1 Tf
8.9663 0 0 8.9663 59.7543 292.1952 Tm
[(Hybridoma)-336.9(production)]TJ
/F4 1 Tf
9.843 0 0 9.843 69.7323 275.7543 Tm
[(A)-307.2(6-week-old)-308(female)-310.9(SpragueDawley)-315.5(\(SD\))-304.6(rat)-309.8(was)-304.6(pur-)]TJ
-1.0137 -1.1116 TD
[(chased)-326.7(from)-316.6(CLEA,)-323.2(Japan)-318.7(\(Tokyo,)-322.2(Japan\).)-323.2(The)-316.7(animal)-321.5(was)]TJ
0 -1.1174 TD
[(housed)-376.2(under)-375.3(specic)-373.8(pathogen-free)-381.9(conditions.)-372.9(Then,)-378.8(ani-)]TJ
0 -1.1116 TD
[(mal)-311.1(experiments)-316.4(were)-312.8(conducted,)-310.7(following)-310.6(relevant)-312(guide-)]TJ
T*
[(lines)-588.5(and)-586.2(regulations)-590.6(to)-589.8(minimize)-590(animal)-586.4(suffering)-586.9(and)]TJ
0 -1.1174 TD
[(distress)-355.2(in)-353.7(the)-350.2(laboratory.)-351(The)-357(Animal)-350(Care)-353.3(and)-350(Use)-356.5(Com-)]TJ
0 -1.1116 TD
[(mittee)-373.4(of)-370.8(Tohoku)-370.7(University)-370.3(approved)-374(animal)-373.3(experiments)]TJ
T*
[(\(Permit)-419.1(No.)-421.2(2019NiA-001\).)-415.9(The)-420.4(rat)-419.3(health)-418.1(was)-419.8(monitored)]TJ
0 -1.1174 TD
[(daily)-381.3(during)-375.3(the)-379(entire)-383.5(4-week)-378.4(duration)-378.8(of)-382.3(the)-373.2(experiment,)]TJ
0 -1.1116 TD
[(and)-327(a)-324.8(reduction)-329.3(of)-318.9(more)-329.3(than)-322.5(25%)-326.9(of)-324.7(the)-321.4(total)-323.8(body)-326.9(weight)]TJ
T*
[(was)-212.5(denoted)-206(as)-204.8(a)-209.6(humane)-206(endpoint.)-209.5(Subsequently,)-209(the)-206.2(rat)-206.2(was)]TJ
T*
[(euthanized)-407.6(through)-399.5(cervical)-405.3(dislocation,)-404.1(after)-405.3(which)-405.1(respi-)]TJ
0 -1.1174 TD
[(ratory)-284.3(and)-280.9(cardiac)-283.2(arrest)-285.3(was)-281.6(used)-281.8(to)-278.8(verify)-284.3(death.)]TJ
1.0137 -1.1116 TD
[(Th)19.6(e)-440(m)0(C)18.6(C)0(R)18.8(2)-433.1(pe)19.7(pt)15(id)20.7(e)-434.2(i)0(m)19.5(m)0(u)19.6(n)0(i)20.7(z)0(a)12.8(t)0(i)20.6(o)0(n)-422.7(m)0(e)18.4(t)0(h)15(o)0(d)-422.7(w)0(a)18.8(s)-438.6(us)21(ed)-429.6(to)]TJ
-1.0137 -1.1116 TD
[(de)19.7(ve)13.9(lo)20.7(p)-300.6(m)15(Ab)14.2(s)-300.4(a)0(g)19.7(a)0(i)19.5(n)0(s)21(t)-300.7(mC)18.6(CR)18.8(2.)-286.8(In)-290.1(br)20.9(ie)13.8(f,)-286.7(on)20.8(e)-301.8(S)0(D)-290.9(r)0(a)19.7(t)-300.7(wa)18.8(s)-300.4(i)0(m)19.5(-)]TJ
0 -1.1174 TD
[(mu)19.6(ni)15(ze)18.5(d,)-281(us)21(in)15(g)-289.1(t)0(h)15(r)0(e)19.7(e)-296(ke)19.7(yh)20.8(ol)20.7(e)-296(l)0(i)20.6(m)0(p)19.6(e)0(t)-285.7(h)0(e)19.7(m)0(o)19.6(c)0(y)19.7(a)0(n)19.7(i)0(n)20.7(-)0(c)14(o)0(n)20.8(j)0(u)20.7(g)0(a)19.7(t)0(e)19.5(d)]TJ
0 -1.1116 TD
[(mC)18.6(CR)18.8(2)-830.5(p)0(e)19.7(p)0(t)20.7(i)0(d)20.7(e)0(s)-821(\()0(1)20.9(0)0(0)]TJ
/F10 1 Tf
10.1313 0 TD
(l)Tj
/F4 1 Tf
.5414 0 TD
[(g)-830.5(o)0(f)-814.3(e)0(a)18.5(c)0(h)-821.2(p)0(e)19.7(p)0(t)20.7(i)0(d)20.7(e)0(\))19.7(,)-832.8(in)20.7(cl)19.5(ud)20.8(in)20.7(g)]TJ
7.3823 0 0 6.5614 59.7543 87.8173 Tm
(1)Tj
9.843 0 0 9.843 63.3826 89.4614 Tm
[(-M)20(ED)18.8(NN)19.1(ML)18.7(PQ)20.1(FI)21(HG)13.3(IL)19.7(ST)19.8(SH)20.1(-)]TJ
7.3823 0 0 6.5614 187.3133 87.8173 Tm
-.0162 Tc
(19)Tj
9.843 0 0 9.843 194.5133 89.4614 Tm
0 Tc
(,)Tj
7.3823 0 0 6.5614 200.9763 87.8173 Tm
(11)Tj
9.843 0 0 9.843 208.1763 89.4614 Tm
[(-I)20.9(HG)19.1(IL)13.9(ST)19.8(SH)20.1(SL)19.8(FT)19.8(RS)20(I)]TJ
-15.0789 -1.1174 TD
(QEL-)Tj
7.3823 0 0 6.5614 82.2614 76.8189 Tm
(29)Tj
9.843 0 0 9.843 89.6315 78.463 Tm
[(,)-245.3(and)]TJ
7.3823 0 0 6.5614 111.1748 76.8189 Tm
(21)Tj
9.843 0 0 9.843 118.6015 78.463 Tm
(-LFTRSIQELDEGATTPYDY-)Tj
7.3823 0 0 6.5614 243.1558 76.8189 Tm
(39)Tj
/F8 1 Tf
9.843 0 0 9.843 250.5826 78.463 Tm
(+)Tj
/F4 1 Tf
.5529 0 TD
(C-terminal)Tj
-19.9401 -1.1116 TD
[(cysteine.)-326.8(The)-322.4(administration)-324.7(was)-327.7(conducted)-324.6(through)-318.8(the)-321.4(in-)]TJ
T*
[(traperitoneal)-514.8(route)-507.9(with)-512.4(an)-504.5(Imject)-511.5(Alum)-507.7(\(Thermo)-512.3(Fisher)]TJ
25.5097 67.9242 TD
[(Scientic,)-512.2(Inc.\).)-513.5(The)-518.3(procedure)-514.4(included)-512.5(three)-514.8(additional)]TJ
0 -1.1174 TD
[(immunization)-248.9(procedures)-250.4(\(100)]TJ
/F10 1 Tf
12.4698 0 TD
(l)Tj
/F4 1 Tf
.5529 0 TD
[(g)-248.8(o)0(f)-244.1(each)-249.8(peptide\),)-250.9(followed)]TJ
-13.0227 -1.1116 TD
[(by)-370.8(a)-376.6(nal)-379.9(booster)-377.4(intraperitoneal)-378.9(injection)-375.6(\(100)]TJ
/F10 1 Tf
19.8134 0 TD
(l)Tj
/F4 1 Tf
.5529 0 TD
[(g)-369.7(o)0(f)-376.5(each)]TJ
-20.3663 -1.1116 TD
[(peptide\))-351.2(2)-346.7(days)-351(before)-354.5(its)-348.9(spleen)-354.4(cells)-353.5(were)-347.4(harvested.)-356.6(The)]TJ
T*
[(harvested)-381.9(spleen)-377.5(cells)-382.3(were)-382(subsequently)-378.3(fused)-380.8(with)-379.9(P3U1)]TJ
0 -1.1174 TD
[(cells,)-547(using)-546.9(polyethylene)-547(glycol)-549.4(1500)-540.1(\(PEG1500;)-547.6(Roche)]TJ
0 -1.1116 TD
[(Diagnostics,)-698.4(Indianapolis,)-698.8(IN\).)-698.7(Then,)-695.6(hybridomas)-698.7(were)]TJ
T*
[(grown)-323.1(in)-324.9(an)-325.9(RPMI)-322.9(1640)-327(medium)-327.1(supplemented)-329(with)-322.3(hypo-)]TJ
0 -1.1174 TD
[(xanthine,)-285.5(aminopterin,)-290.2(and)-280.9(thymidine)-289.2(for)-285.5(selection)-290.1(\(Thermo)]TJ
0 -1.1116 TD
[(Fis)14.2(her)-459.4(Sci)12.8(ent)12.7(ic)12.8(,)-470(Inc)12.8(.\))12.8(.)-475.7(Cul)12.8(tu)15(red)-465.2(sup)14.2(ern)12.9(ata)11.5(nt)14.9(s)-473.2(wer)12(e)-474.5(na)13(ll)14.8(y)]TJ
T*
[(scr)13(een)17.4(ed)-181.9(usi)14(ng)-175(enz)11.7(yme)11.6(-li)13.7(nk)15.1(ed)-181.9(imm)17.2(uno)14(sor)14.2(ben)12.8(t)-179.8(ass)13.2(ay)-181.9(\(EL)11.6(IS)15.3(A\))]TJ
0 -1.1174 TD
[(and)-263.6(ow)-269(cy)13.9(tom)12.6(etr)12.7(ic)-268.4(ana)11.7(lys)14(is.)]TJ
ET
q
1 i
311.414 558.652 m
549.354 558.652 l
549.354 143.093 l
311.414 143.093 l
W n
q
238.023 0 0 415.559 311.414 143.093 cm
/Im2 Do
Q
Q
BT
/F5 1 Tf
9.845 0 0 9.845 310.8472 126.3118 Tm
[(FIG.)-567.1(1.)]TJ
/F4 1 Tf
4.3477 0 TD
[(A)-571.9(schematic)-573.5(procedure)-571(of)-566.3(anti-mCCR2)-574.2(mAbs)]TJ
-4.3477 -1.0135 TD
[(production.)-429.4(The)-425.7(rat)-430.5(was)-430.9(intraperitoneally)-437.2(immunized)-428.5(with)]TJ
0 -1.0077 TD
[(mCCR2)-274(peptides.)-278.7(Screening)-271.6(was)-275.5(then)-276(conducted)-277.5(by)-272.6(ELISA,)]TJ
0 -1.0135 TD
[(using)-362(mCCR2)-366.1(peptides,)-365.1(and)-366.9(ow)-366.4(cytometry)-364(using)-367.7(parental)]TJ
T*
[(cells)-710(and)-712.4(mCCR2-overexpressed)-718.3(CHO-K1)-711.9(cells.)-707.6(CHO,)]TJ
T*
[(Chinese)-517(hamster)-522.9(ovary;)-519.8(ELISA,)-518.1(enzyme-linked)-525.8(immuno-)]TJ
0 -1.0077 TD
[(sorbent)-716.4(assay;)-716.4(mAbs,)-717.4(monoclonal)-722(antibodies;)-716.3(mCCR2,)]TJ
0 -1.0135 TD
[(mouse)-335.4(CC)-332.2(chemokine)-336.2(receptor)-339.8(type-2.)]TJ
/F6 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(ANTI-MOUSE)-342.7(CCR2)-335.3(MONOCLONAL)-336.8(ANTIBODY)-31028.9(81)]TJ
ET
endstream
endobj
29 0 obj
<>stream
Adobe d C
b
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? Nq[ύr@]siw֫E,
5{gjc-~ayr@>dx5*3H^5P=Ao#?',(1\=јn*F[Pkyk`&樁bU,=ґ$'
O5YLhgPcs˟7j:?uei'$CFxC'N:sʗlT
{JaPʼxwu0[MOifٞV&^(jX~\''5=bV)$qhUzR\@~VhFj]Wٖ6!_z-{E."x$1E$L ϗ<_Zz
GV1QŨw{?M|6